enVVeno Medical Corp. (NVNO)
11.24
-0.25
(-2.18%)
USD |
NASDAQ |
Sep 09, 10:55
enVVeno Medical Shareholders Equity (Quarterly) : 20.67M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 20.67M |
| March 31, 2026 | 23.75M |
| December 31, 2025 | 27.13M |
| September 30, 2025 | 29.45M |
| June 30, 2025 | 33.06M |
| March 31, 2025 | 38.31M |
| December 31, 2024 | 42.16M |
| September 30, 2024 | 47.37M |
| June 30, 2024 | 38.42M |
| March 31, 2024 | 42.37M |
| December 31, 2023 | 46.20M |
| September 30, 2023 | 24.92M |
| June 30, 2023 | 28.81M |
| March 31, 2023 | 34.13M |
| December 31, 2022 | 38.73M |
| September 30, 2022 | 42.67M |
| June 30, 2022 | 46.56M |
| March 31, 2022 | 51.32M |
| December 31, 2021 | 54.40M |
| September 30, 2021 | 58.05M |
| Date | Value |
|---|---|
| June 30, 2021 | 40.87M |
| March 31, 2021 | 43.01M |
| December 31, 2020 | 7.098M |
| September 30, 2020 | 4.795M |
| June 30, 2020 | 0.3694M |
| March 31, 2020 | -0.0146M |
| December 31, 2019 | 0.9899M |
| September 30, 2019 | 3.084M |
| June 30, 2019 | 4.652M |
| March 31, 2019 | 2.865M |
| December 31, 2018 | 2.036M |
| September 30, 2018 | 3.542M |
| June 30, 2018 | 4.611M |
| March 31, 2018 | -10.57M |
| December 31, 2017 | -5.960M |
| September 30, 2017 | -3.594M |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | -0.2837M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Abbott Laboratories | 51.11B |
| AngioDynamics, Inc. | 170.82M |
| Alphatec Holdings, Inc. | 11.53M |
| AtriCure, Inc. | 516.43M |
| Baxter International, Inc. | 6.206B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 22.66M |
| Total Liabilities (Quarterly) | 1.99M |
| Debt to Equity Ratio | 0.0244 |
| Current Ratio | 11.70 |
| Net Debt Paydown Yield | 1.32% |